טוען...
Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
OBJECTIVES: Studies of the use of IV N-acetylcysteine in the management of non-acetaminophen-induced acute liver failure have evaluated various dosing regimens. The only randomized trial studying this application described a 72-hour regimen. However, observational studies have reported extended dura...
שמור ב:
| הוצא לאור ב: | Crit Care Explor |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams & Wilkins
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8133178/ https://ncbi.nlm.nih.gov/pubmed/34036270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000411 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|